CORONAVIRUS NEWS

Detection of IgG antibodies against four SARS-CoV-2 antigens

Bio-Rad Laboratories has announced the launch of the Bio-Plex Pro Human IgG SARS-CoV-2 N/RBD/S1/S2 4-Plex Panel.

Increasing laboratory efficiency in a remote environment: a webinar

The SARS-CoV-2 pandemic has resulted in a challenging work environment. This has made the development and commercialisation of vaccines, treatments and critically needed PCR-based and serological diagnostics especially challenging.

A milestone and investment in COVID-19 testing capacity

Randox has processed its 10-millionth sample for the UK’s COVID-19 National Testing Programme, making it the first Pillar 2 testing laboratory to achieve this milestone, having invested £85 million since March 2020 in facilities and equipment.

Evaluation of SARS-CoV-2 lateral-flow test with clinical samples

Avacta Group has received the first data for its SARS-CoV-2 rapid antigen test from ongoing clinical studies in Europe and the UK, which show excellent performance in identifying patients with an infectious viral load and no false positive results.

Antimicrobial resistance: a problem with disinfectants

South African scientists warn of grave danger that disinfectant use against SARS-CoV-2 could be helping bacteria to become resistant to disinfectants.

A need to reconfigure and an opportunity to transform

The in vitro diagnostics industry has been at the forefront of the fight against SARS-CoV-2 and medicine’s response to cases of severe COVID-19 disease.

Rapid antigen test and support for SARS-CoV-2 testing

Avacta Group and Mologic have entered a partnership to market Avacta’s AffiDX SARS-CoV-2 lateral-flow rapid antigen test. Avacta will also support antigen testing in low- and middle-income countries by providing access to Avacta’s spike antigen test.

The infection challenging the world: a virtual meeting in May

The British Society for Microbial Technology (BSMT) will hold a virtual conference entitled ‘COVID-19 – The Infection Challenging the World' over four days in May. Click on this story for an update on the conference programme and commercial support.

High-throughput bead-assisted mass spectrometry test for SARS-CoV-2

Avacta Group has entered into a collaboration agreement with Bruker to evaluate the Affimer-based, bead-assisted mass spectrometry (BAMS) SARS-CoV-2 assay, developed with Adeptrix.

The infection that challenged the world: a date for your diary

The British Society for Microbial Technology (BSMT) is organising a virtual conference entitled ‘COVID-19 – The Infection that Challenged the World: Is Necessity the Mother of Invention?’

Launch of SARS-CoV-2 IgG II antibody test

Beckman Coulter has launched its Access SARS-CoV-2 IgG II assay in countries accepting the CE mark. The new Access SARS-CoV-2 IgG II assay quantitatively measures a patient’s level of antibodies in response to a previous SARS-CoV-2 infection.

SARS-CoV-2 antibody test to determine previous infection

Randox Laboratories has launched its new SARS-CoV-2 IgG test, utilising patented Randox Biochip Technology to simultaneously detect IgG antibodies that are reactive to both the spike receptor binding domain (RBD) and nucleocapsid protein (NP).

Quantitative large-scale immunosequencing solution

Q2 Solutions, a global clinical trial laboratory services organisation, resulting from an IQVIA and Quest Diagnostics joint venture, has announced a partnership with Adaptive Biotechnologies, a pioneer and leader in immune-driven medicine.

Rapid antigen test receives CE mark approval

Mologic a developer of lateral-flow and rapid diagnostic technologies, has announced that its professional-use COVID-19 Rapid Antigen Test has now been certified with a CE mark.

Software update results in a faster PCR test for SARS-CoV-2

Introduction of improved software for the Vivalytic analysis device means that the CE-marked Vivalytic SARS-CoV-2 rapid coronavirus test, which uses the polymerase chain reaction (PCR), now delivers its results even faster.

Delivering ultralow-temperature freezers to vaccination centres

Scientific Laboratory Supplies (SLS) and international life sciences company Eppendorf have been chosen to provide ultralow-temperature (ULT) freezers for the country’s supply of COVID-19 vaccines.

Vitamin C: a game-changer for COVID-19 patients

Vitamin C can save the lives of those badly affected by SARS-CoV-2 infection and COVID-19 disease, and make symptoms of milder infections less severe. This is a key finding from a major review just published by senior experts from around the world.

Approval of first coronavirus vaccine: comment from BIVDA

British In Vitro Diagnostics Association (BIVDA) Chief Executive Doris-Ann Williams has welcomed the confirmation of the first COVID-19 vaccine to be approved by British regulators.

Accurate quantitative SARS-CoV-2 antibody test kit

EKF Diagnostics has introduced the Kantaro COVID-SeroKlir SARS-CoV-2 IgG antibody test kit, one of the first tests to measure precisely levels of SARS-CoV-2 neutralising antibodies in individuals.

SARS-CoV-2: testing for the infectious

In a boost to the daily testing scheme announced by the government, British firm Iceni Diagnostics has developed a solution that can identify whether or not patients are actually infectious.

Upcoming Events

Hands-free, safe and remote dissection: a Menarini webinar

Online
4 March 2021

COVID-19 - The Infection Challenging the World

Online
11-14 May 2021

Lab Innovations 2021

NEC, Birmingham
3-4 November 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Upcoming Events

Hands-free, safe and remote dissection: a Menarini webinar

Online
4 March 2021

COVID-19 - The Infection Challenging the World

Online
11-14 May 2021

Lab Innovations 2021

NEC, Birmingham
3-4 November 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022